Skip to main content
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.500
+0.130 (9.49%)
At close: Mar 9, 2026, 4:00 PM EDT
1.490
-0.010 (-0.67%)
After-hours: Mar 9, 2026, 7:50 PM EDT

Pyxis Oncology Revenue

Pyxis Oncology had revenue of $2.82M in the twelve months ending September 30, 2025, down -82.53% year-over-year. In the year 2024, Pyxis Oncology had annual revenue of $16.15M.

Revenue (ttm)
$2.82M
Revenue Growth
-82.53%
P/S Ratio
31.57
Revenue / Employee
$64,091
Employees
44
Market Cap
93.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.15M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 58.42M
Verrica Pharmaceuticals 30.83M
Kazia Therapeutics 1.20M
Seres Therapeutics 351.00K
iBio, Inc. 300.00K
aTyr Pharma 190.00K
Revenue Rankings

PYXS News

More News